UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 180

Sortiert nach

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification

Journal of clinical oncology, 2011-07, Vol.29 (21), p.2904-2909

2011

Volltextzugriff (PDF)

Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study

PloS one, 2015-11, Vol.10 (11), p.e0143515-e0143515

2015

Volltextzugriff (PDF)

Health care inequality under different medical insurance schemes in a socioeconomically underdeveloped region of China: a propensity score matching analysis

BMC public health, 2019-10, Vol.19 (1), p.1373-1373, Article 1373

2019

Volltextzugriff (PDF)

Association of ESR1 polymorphism rs2234693 and rs9340799 with postmenopausal osteoporosis in a Chinese population

BMC musculoskeletal disorders, 2020-06, Vol.21 (1), p.346-346, Article 346

2020

Volltextzugriff (PDF)

Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma

Thoracic cancer, 2021-10, Vol.12 (19), p.2585-2593

2021

Volltextzugriff (PDF)

Concurrent chemotherapy and first‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first‐line treatment in advanced lung adenocarcinoma harboring an EGFR mutation

Thoracic cancer, 2021-08, Vol.12 (16), p.2233-2240

2021

Volltextzugriff (PDF)

Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments

BMJ open, 2020-02, Vol.10 (2), p.e032336-e032336

2020

Volltextzugriff (PDF)

Thoracic radiation therapy improves the overall survival of patients with extensive‐stage small cell lung cancer with distant metastasis

Cancer, 2011-12, Vol.117 (23), p.5423-5431

2011

Volltextzugriff (PDF)

Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations

Thoracic cancer, 2021-11, Vol.12 (21), p.2924-2932

2021

Volltextzugriff (PDF)

Efficacy and safety profile of combining programmed cell death‐1 (PD‐1) inhibitors and antiangiogenic targeting agents as subsequent therapy for advanced or metastatic non‐small cell lung cancer (NSCLC)

Thoracic cancer, 2021-09, Vol.12 (17), p.2360-2368

2021

Volltextzugriff (PDF)

Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma

Radiation oncology (London, England), 2022-03, Vol.17 (1), p.58-58, Article 58

2022

Volltextzugriff (PDF)

Study protocol: A single‐arm, multicenter, phase II trial of camrelizumab plus apatinib for advanced nonsquamous NSCLC previously treated with first‐line immunotherapy

Thoracic cancer, 2021-10, Vol.12 (20), p.2825-2828

2021

Volltextzugriff (PDF)

Efficacy of dacomitinib in patients with EGFR‐mutated NSCLC and brain metastases

Thoracic cancer, 2021-12, Vol.12 (24), p.3407-3415

2021

Volltextzugriff (PDF)

Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2012-07, Vol.77 (1), p.89-96

2012

Volltextzugriff (PDF)

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer

Radiation oncology (London, England), 2011-03, Vol.6 (1), p.24-24, Article 24

2011

Volltextzugriff (PDF)

Correlation of FGFR2 rs2981582 polymorphisms with susceptibility to breast cancer: a case-control study in a Chinese population

Journal of international medical research, 2019-10, Vol.47 (10), p.4753-4763

2019

Volltextzugriff (PDF)

Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial

BMC cancer, 2020-04, Vol.20 (1), p.278-10, Article 278

2020

Volltextzugriff (PDF)

Clinical outcome, long‐term survival and tolerability of sequential therapy of first‐line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in China

Thoracic cancer, 2022-01, Vol.13 (1), p.107-116

2022

Volltextzugriff (PDF)

Clinical Significance of Tumor Marker Detection in Patients  with Advanced Squamous Cell Carcimoma of the Lung

Zhongguo fei ai za zhi, 2016-10, Vol.19 (10), p.641-647

2016

Volltextzugriff (PDF)

Driven Gene in Patients with Lung Squamous Cell Carcinoma:  Analysis of Clinicopathologic Characteristics and Prognosis

Zhongguo fei ai za zhi, 2016-10, Vol.19 (10), p.648-652

2016

Volltextzugriff (PDF)

Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma

Scientific reports, 2017-05, Vol.7 (1), p.1453-9, Article 1453

2017

Volltextzugriff (PDF)

Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK‐positive non‐small cell lung cancer: A retrospective, real‐world study

Cancer medicine (Malden, MA), 2019-10, Vol.8 (13), p.5823-5830

2019

Volltextzugriff (PDF)

Utility of NSE, ProGRP and LDH in Diagnosis and Treatment in Patients with Small Cell Lung Cancer

Zhongguo fei ai za zhi, 2016-09, Vol.19 (9), p.590-594

2016

Volltextzugriff (PDF)

Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma

Zhongguo fei ai za zhi, 2017-10, Vol.20 (10), p.690-694

2017

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(162)

Publikationsform

Artikel
(180)

Sprache

Englisch
(148)
Chinesisch
(33)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Humans
(180)
Male
(167)
Female
(164)
Adult
(135)
Science & Technology
(132)
Aged
(126)
Life Sciences & Biomedicine
(124)
Retrospective Studies
(57)
Lung Cancer
(54)
Oncology
(54)
Young Adult
(46)
Mutation
(39)
Aged, 80 And Over
(38)
Chemotherapy
(38)
Lung Neoplasms - Drug Therapy
(38)
China
(33)
Cancer Therapies
(32)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(32)
Adolescent
(30)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification

Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study

Health care inequality under different medical insurance schemes in a socioeconomically underdeveloped region of China: a propensity score matching analysis

Association of ESR1 polymorphism rs2234693 and rs9340799 with postmenopausal osteoporosis in a Chinese population

Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma

Concurrent chemotherapy and first‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first‐line treatment in advanced lung adenocarcinoma harboring an EGFR mutation

Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments

Thoracic radiation therapy improves the overall survival of patients with extensive‐stage small cell lung cancer with distant metastasis

Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations

Efficacy and safety profile of combining programmed cell death‐1 (PD‐1) inhibitors and antiangiogenic targeting agents as subsequent therapy for advanced or metastatic non‐small cell lung cancer (NSCLC)

Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma

Study protocol: A single‐arm, multicenter, phase II trial of camrelizumab plus apatinib for advanced nonsquamous NSCLC previously treated with first‐line immunotherapy

Efficacy of dacomitinib in patients with EGFR‐mutated NSCLC and brain metastases

Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer

Correlation of FGFR2 rs2981582 polymorphisms with susceptibility to breast cancer: a case-control study in a Chinese population

Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial

Clinical outcome, long‐term survival and tolerability of sequential therapy of first‐line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in China

Clinical Significance of Tumor Marker Detection in Patients  with Advanced Squamous Cell Carcimoma of the Lung

Driven Gene in Patients with Lung Squamous Cell Carcinoma:  Analysis of Clinicopathologic Characteristics and Prognosis

Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma

Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK‐positive non‐small cell lung cancer: A retrospective, real‐world study

Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study

Utility of NSE, ProGRP and LDH in Diagnosis and Treatment in Patients with Small Cell Lung Cancer

Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma

Aktive Filter

Suchergebnisse filtern